Nurse managing IBD virtual clinic with technology symbols

IBD Advances: How Nurses are Revolutionizing Crohn's and Colitis Care

Kai Mendoza monogram
Kai Mendoza in Health & Wellness October 2026 • 4 min read.

"Explore the latest innovations in inflammatory bowel disease (IBD) management, including virtual clinics, accelerated infusions, and home testing, and how nurses are playing a pivotal role in enhancing patient care and outcomes."


Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, presents significant challenges for patients and healthcare providers alike. Effective management requires a multifaceted approach, integrating medical, surgical, and nursing care to optimize patient outcomes.

Traditionally, IBD care has relied heavily on hospital visits and conventional treatment methods. However, recent innovations are shifting the paradigm, with nurses at the forefront of implementing cutting-edge strategies to enhance patient care. These advancements include virtual clinics, accelerated infusions of biosimilar medications, and convenient home testing systems, all designed to improve accessibility, efficiency, and patient satisfaction.

This article explores these transformative approaches, highlighting how nurses are leveraging technology and innovative protocols to revolutionize IBD management. From streamlining communication and treatment decisions in perianal Crohn's disease to ensuring safe and efficient biosimilar infusions and empowering patients with at-home monitoring tools, nurses are playing a pivotal role in shaping the future of IBD care.

AI Search Multiple angles on this topic

What IBD Affects

Inflammatory bowel disease (IBD) is a group of long-term conditions involving inflammation in the digestive tract. Crohn's disease and ulcerative colitis are its principal types. Crohn's disease can affect the small and large intestines as well as the mouth, esophagus, stomach, and anus, while ulcerative colitis primarily affects the colon and rectum. Flares may cause symptoms such as intense stomach cramps and diarrhea, and IBD can also affect physical health and emotional well-being.

The Established IBD Framework

Johns Hopkins Medicine describes IBD as the common name for Crohn's disease and ulcerative colitis, two chronic inflammatory diseases of the intestinal tract. The source reports that these conditions affect as many as 1.6 million Americans, with most diagnoses occurring before age 35. This established disease framework identifies the principal conditions involved, but the source excerpt does not detail specific treatment methods or their limitations.

A Developing Medical History

The supplied sources do not provide a detailed historical timeline for Crohn's disease, ulcerative colitis, or nursing-led IBD care. A cautious overview would recognize IBD as a long-term group of inflammatory digestive conditions whose understanding and management have developed over time. Specific milestones and foundational discoveries would require additional historical sources.

Virtual Clinics: Streamlining Care for Perianal Crohn's Disease

Nurse managing IBD virtual clinic with technology symbols

Perianal Crohn's disease (PCD) presents unique challenges due to its complex nature and the need for coordinated medical, surgical, and nursing interventions. Traditional care models often involve fragmented communication and delays in treatment, leading to suboptimal outcomes for patients.

To address these challenges, a multidisciplinary team at Guy's and St Thomas' NHS Foundation Trust in London developed a perianal virtual clinic (PVC). This innovative approach brings together gastroenterologists, surgeons, and clinical nurse specialists for weekly virtual reviews of patients with complex PCD. The PVC aims to:

  • Optimize medical management using drug levels and anti-drug antibody assessments.
  • Expedite radiological assessments and clinic reviews as needed.
  • Provide timely surgical interventions for patients with acute PCD activity.
  • Offer a seamless one-stop service for assessment, treatment planning, and surgical pre-assessment.
AI Search Multiple angles on this topic

An Evolving Evidence Base

The supplied material does not identify a specific recent study, review, dataset, or research finding about advances in Crohn's and colitis care. Broadly, IBD research continues to examine chronic inflammation in the digestive tract and its effects beyond the gut. More precise conclusions about current research would require dedicated, up-to-date research sources.

Limits of the Available Evidence

The supplied material does not document particular treatment failures, counterarguments, or disagreements about nurse-led IBD care. It does indicate that IBD can involve recurring flares and periods when symptoms decrease or disappear, suggesting that disease experiences may vary over time. Specific criticisms or failure rates cannot be established from the available sources.

Crohn's Disease and Ulcerative Colitis

A limited comparison can be made between the two principal IBD types. Crohn's disease may affect multiple parts of the digestive tract, including the small intestine, large intestine, mouth, esophagus, stomach, and anus. Ulcerative colitis primarily affects the colon and rectum. The supplied sources do not provide a broader comparison of outcomes, treatments, or nursing models.

The results of their study, which reviewed PVC activity and outcomes between January and June 2016, demonstrated the effectiveness of this approach. During this period, the team reviewed 69 virtual patients and 31 acute cases face-to-face. The PVC facilitated timely surgical interventions, with 31 patients booked for examination under anesthesia (EUA) directly from the virtual clinic. Furthermore, 45% of these patients were approved to commence biologic therapy following the EUA. The PVC also enabled efficient optimization of medical therapies, with 14 patients booked for routine outpatient appointments and 7 scheduled for face-to-face assessments to optimize their treatment regimens.

The Future of IBD Care: A Collaborative Approach

The innovations discussed in this article highlight the transformative potential of nursing-led initiatives in IBD management. By embracing virtual clinics, accelerated infusions, and home testing systems, healthcare providers can improve patient access, enhance treatment efficiency, and empower patients to take an active role in their care.

AI Search Multiple angles on this topic

Clarifying the IBD Name

The supplied source identifies IBD as an abbreviation used in several names associated with Investor's Business Daily, including IBD Digital, IBD Live, IBD Weekly, and MarketSurge. It also states that these marks are trademarks owned by Investor's Business Daily, LLC. This source does not provide medical expert commentary or evidence about Crohn's disease, ulcerative colitis, or nursing care.

The Need for Further Evidence

The supplied sources do not identify specific future technologies, therapies, or nursing innovations for IBD care. Future progress may depend on continued efforts to understand and manage chronic inflammation in the digestive tract. Claims about next frontiers should be supported by dedicated research and clinical sources.

IBD Beyond the Digestive Tract

The available material indicates that IBD is a long-term condition involving inflammation in the digestive tract. It also notes that IBD can affect overall physical health and emotional well-being, not only the gut. The sources do not provide detailed evidence about healthcare access, system-wide disparities, or other broader challenges.

Living With Flares

IBD may involve periods when symptoms flare and periods when they decrease or disappear. Flares can include intense stomach cramps and diarrhea, while the condition may also affect emotional well-being. The supplied sources do not specifically measure the role of nurses or describe individual patient experiences.

How these care comparisons differ

A telemedicine meta-analysis included 17 randomized trials with 2,571 participants, but the remote-care programmes in the underlying trials were described unclearly, making replication difficult. The review also could not judge access, patient approval, professional involvement, costs, or time.[1] [2]

For web-based telemanagement, a reported improvement in disease activity and social activities over standard care was not statistically significant; the source attributes this uncertainty to small sample size and short follow-up. This limits how strongly the apparent difference can be interpreted.[3]

What remains uncertain about IBD care

  • How much confidence should patients and clinicians place in a fecal calprotectin result when measurements vary and no globally accepted cutoff exists?[4]
  • Could stool consistency affect how fecal calprotectin levels are interpreted, given the reported correlation between more liquid stools and higher concentrations?[4]

Sources

  1. Role of Telemedicine in Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials (pmc.ncbi.nlm.nih.gov)
  2. The use of technology for remote care in inflammatory bowel disease | Cochrane (www.cochrane.org)
  3. A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Randomized Controlled Trial (pmc.ncbi.nlm.nih.gov)
  4. International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases (onlinelibrary.wiley.com)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is Inflammatory Bowel Disease (IBD) and what challenges does it pose?

Inflammatory Bowel Disease (IBD) encompasses two main conditions: Crohn's disease and ulcerative colitis. Both cause significant challenges for patients and healthcare providers. Effective management of IBD requires a comprehensive approach integrating medical, surgical, and nursing care to achieve optimal patient outcomes. The disease itself presents symptoms like abdominal pain, diarrhea, and fatigue, while its chronic nature and potential complications can dramatically impact a patient's quality of life.

2

How are virtual clinics revolutionizing the care for Perianal Crohn's Disease (PCD)?

Virtual clinics, specifically the perianal virtual clinic (PVC), are transforming the management of Perianal Crohn's Disease (PCD). These clinics bring together gastroenterologists, surgeons, and clinical nurse specialists for weekly virtual reviews. The PVC optimizes medical management using drug levels and anti-drug antibody assessments, expedites radiological assessments, provides timely surgical interventions, and offers a seamless one-stop service. Studies, like the one at Guy's and St Thomas' NHS Foundation Trust, demonstrated the PVC's effectiveness, showing it facilitates timely surgical interventions and efficient optimization of medical therapies, leading to improved patient outcomes.

3

What are accelerated infusions and how do they benefit patients with IBD?

The article highlights the use of accelerated infusions of biosimilar medications, which are infusions that are administered more quickly than traditional methods. While the article doesn't explain the specific process, the goal is to improve treatment efficiency. This means patients spend less time at the clinic and receive their medications faster, improving their convenience and potentially increasing adherence to treatment plans. While the article doesn't provide detailed data, faster infusions are designed to enhance the overall patient experience.

4

How do nurses contribute to the advancements in IBD care, specifically regarding virtual clinics and home testing?

Nurses play a crucial role in the implementation of advancements like virtual clinics, accelerated infusions of biosimilar medications, and home testing systems. In the context of virtual clinics for Perianal Crohn's Disease, clinical nurse specialists are integral members of the multidisciplinary team, working alongside gastroenterologists and surgeons to review patient cases and coordinate care. Their involvement ensures seamless communication, efficient treatment planning, and timely interventions. Regarding home testing, nurses are likely involved in educating patients, providing instructions, and interpreting results, empowering patients to actively monitor their condition and participate in their care.

5

Besides virtual clinics, what other innovative approaches are improving IBD patient care and outcomes?

Besides the perianal virtual clinics (PVC), the article mentions accelerated infusions of biosimilar medications and at-home calprotectin testing as innovative approaches improving IBD patient care. While the specific details of accelerated infusions are not elaborated, they are designed to improve treatment efficiency. Home testing for calprotectin allows for convenient monitoring of inflammation levels, enabling patients to take a more active role in their care and allowing for more timely adjustments to treatment plans. These advancements collectively improve patient access to care, enhance treatment efficiency, and empower patients, highlighting a shift towards a more patient-centered approach to IBD management.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.